Dural Muhammet, Eerenberg Frederieke, Smits Karin C, Nguyên Uyên Châu, Vernooy Kevin, van Stipdonk Antonius M W
Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Center+ (MUMC+), 6229 ER Maastricht, The Netherlands.
Department of Cardiology, Eskişehir Osmangazi University Faculty of Medicine, Eskişehir 26040, Turkey.
J Cardiovasc Dev Dis. 2025 May 7;12(5):177. doi: 10.3390/jcdd12050177.
Vectorcardiography (VCG) is an electrophysiological investigation technique, giving supplementary information about the electrical activation of the heart, compared to traditional 12-lead electrocardiography (ECG). Whereas the 12-lead ECG has found its way into global clinical cardiology practice in numerous cardiac pathophysiological instances, VCG has not. In an investigation of the electrical activation of the heart in cardiac resynchronization therapy (CRT), in order to understand the baseline pathology in potentially eligible patients, and to understand and optimize CRT-derived paced activation of the heart in the therapy's recipients, all of these aspects are essential to the success of the therapy. Due to a consistently present group of non-responders in CRT, VCG has gained interest as a potential improvement in this field. This review comprehensively summarizes the contemporary evidence for the additional value of VCG in CRT, as well as current deficiencies in evidence, to support its implementation in global practice in addition to, or as a substitution for, traditional 12-lead ECG.
向量心电图（VCG）是一种电生理检查技术，与传统的12导联心电图（ECG）相比，它能提供有关心脏电活动的补充信息。虽然12导联心电图已在众多心脏病理生理情况下进入全球临床心脏病学实践，但VCG却没有。在心脏再同步治疗（CRT）中对心脏电活动进行研究时，为了了解潜在符合条件患者的基线病理情况，并了解和优化CRT对治疗接受者心脏的起搏激活，所有这些方面对治疗的成功都至关重要。由于CRT中始终存在一组无反应者，VCG作为该领域潜在的改进方法受到了关注。本综述全面总结了VCG在CRT中附加价值的当代证据以及当前证据的不足，以支持其在全球实践中作为传统12导联心电图的补充或替代方法加以应用。
